Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual

With the goal of examining the functional diversity of human immunodeficiency virus type 1 (HIV-1) env genes within the peripheral blood mononuclear cells of an asymptomatic individual, we substituted four complete env genes into the replication-competent NL4-3 provirus. Despite encoding full-length open reading frames for gp120 and gp41 and the second coding exon of tat and rev, each chimera was replication defective. Site-directed mutagenesis of codon 78 in the Rev activation domain (from a hitherto unique Ile to the subtype B consensus Leu) partially restored infectivity for two of three chimeras tested. Similarly, mutagenesis of rev codon 78 of NL4-3 from Leu to Ile partially attenuated this virus. Ile-78 was found in all 13 clones examined from samples taken from this asymptomatic subject 4.5 years after infection, including 9 from peripheral blood mononuclear cells and 4 from a virus isolate, as well as 4 additional clones each from peripheral blood mononuclear cells sampled 37 and 51 months later. We next examined conservation of the Rev activation domain within and among long-term survivors (LTS) and patients with AIDS, as well as T-cell-line-adapted strains of HIV-1. Putative attenuating mutations were found in a minority of sequences from all five LTS and two of four patients with AIDS. Of the 11 T-cell-line-adapted viruses examined, none had these changes. Among and within LTS virus population had marginally higher levels of diversity in Rev than in Env; patients with AIDS had similar levels of diversity in the two reading frames; and T-cell-line-adapted viruses had higher levels of diversity in Env. These results are consistent with the hypothesis that asymptomatic individuals harbor attenuated variants of HIV-1 which correlate with and contribute to their lack of disease progression.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  John W. Mellors,et al.  Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .

[3]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .

[4]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[5]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[6]  B. Walker,et al.  Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays , 1994, Journal of virology.

[7]  S. Knapp,et al.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon , 1994, Journal of virology.

[8]  Groen,et al.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate , 1994, Journal of virology.

[9]  D. Baltimore,et al.  Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Kingsley,et al.  Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. , 1993, Virology.

[11]  E. Vittinghoff,et al.  The characterization of non‐progressors: long‐term HIV‐1 infection with stable CD4+ T‐cell levels , 1993, AIDS.

[12]  B. Margolin,et al.  V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.

[13]  H. Schuitemaker,et al.  Relation of phenotype evolution of HIV-1 to envelope V2 configuration. , 1993, Science.

[14]  A. Osterhaus,et al.  Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation , 1993, Journal of virology.

[15]  J. Sodroski,et al.  Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody , 1993, Journal of virology.

[16]  G. Pantaleo,et al.  The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism , 1993, Journal of virology.

[17]  J. Levy,et al.  Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages , 1993, Journal of clinical microbiology.

[18]  O. Bagasra,et al.  Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[20]  D. Costagliola,et al.  Towards a new predictor of AIDS progression through the quantisation of HIV‐1 DNA copies by PCR in HIV‐infected individuals , 1992, British journal of haematology.

[21]  B. Cullen,et al.  Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2 , 1992, Journal of virology.

[22]  C. Kuiken,et al.  Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype , 1992, Journal of virology.

[23]  H. Mitsuya,et al.  Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. , 1992, AIDS research and human retroviruses.

[24]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[25]  J. Sodroski,et al.  Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus , 1992, Journal of virology.

[26]  J. Hauber,et al.  Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange , 1992, Journal of virology.

[27]  E. G. Shpaer,et al.  Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro , 1992, Journal of virology.

[28]  R. Coutinho,et al.  HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay , 1992, AIDS.

[29]  T. Hope,et al.  Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Malim,et al.  Mutational definition of the human immunodeficiency virus type 1 Rev activation domain , 1991, Journal of virology.

[31]  J. Hauber,et al.  trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences. , 1991, Virology.

[32]  M. Malim,et al.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency , 1991, Cell.

[33]  P. Sharp,et al.  Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Schuitemaker,et al.  Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture , 1991, Journal of virology.

[35]  J. Sodroski,et al.  Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion , 1990, Journal of virology.

[36]  D. Serwadda,et al.  Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates. , 1990, AIDS research and human retroviruses.

[37]  J. Mullins,et al.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 , 1990, Nature.

[38]  E. Freed,et al.  Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Delwart,et al.  Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat. , 1990, AIDS research and human retroviruses.

[40]  S. Le,et al.  A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. , 1990, Nucleic acids research.

[41]  Bryan R. Cullen,et al.  HIV-1 structural gene expression requires binding of the rev trans-activator to its RNA target sequence , 1990, Cell.

[42]  R. Garry,et al.  A general model for the transmembrane proteins of HIV and other retroviruses. , 1989, AIDS research and human retroviruses.

[43]  M. Malim,et al.  Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function , 1989, Cell.

[44]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[45]  B. Franza,et al.  Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins , 1989, Journal of virology.

[46]  G. Myers,et al.  Molecular characterization of HIV-1 isolated from a serum collected in 1976: nucleotide sequence comparison to recent isolates and generation of hybrid HIV. , 1989, AIDS research and human retroviruses.

[47]  F. Witney,et al.  Efficient site-directed in vitro mutagenesis using phagemid vectors. , 1989, BioTechniques.

[48]  M. Malim,et al.  Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein , 1988, Nature.

[49]  J. Jurka,et al.  Multiple aligned sequence editor (MASE). , 1988, Trends in biochemical sciences.

[50]  M. Reitz,et al.  Envelope sequences of two new United States HIV-1 isolates. , 1988, Virology.

[51]  Huisman,et al.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.

[52]  C. Cheng‐Mayer,et al.  Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.

[53]  Gilcher Ro Human retroviruses and AIDS. , 1988 .

[54]  J. Mullins,et al.  Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. , 1988, Science.

[55]  M. Siekevitz,et al.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. , 1987, Science.

[56]  J. Albert,et al.  REPLICATIVE CAPACITY OF HUMAN IMMUNODEFICIENCY VIRUS FROM PATIENTS WITH VARYING SEVERITY OF HIV INFECTION , 1986, The Lancet.

[57]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[58]  R. Schooley,et al.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. , 1985, The New England journal of medicine.

[59]  M. Hirsch,et al.  Primary human T-lymphotropic virus type III infection. , 1985, Annals of internal medicine.

[60]  K. Nilsson,et al.  In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. , 1991, Journal of acquired immune deficiency syndromes.

[61]  M. Popovič,et al.  Virus Isolation and Production , 1990 .

[62]  S. Ruben,et al.  Structural and functional characterization of the human immunodeficiency virus rev protein. , 1989, Journal of acquired immune deficiency syndromes.

[63]  R. Gilcher Human retroviruses and AIDS. , 1988, The Journal of the Oklahoma State Medical Association.

[64]  B. Seed An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2 , 1987, Nature.

[65]  D. Salberg Virologic studies in a case of transfusion-associated AIDS. , 1985, The New England journal of medicine.